BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27197524)

  • 1. Diagnostic Accuracy of BRAF Immunohistochemistry in Colorectal Cancer: a Meta-Analysis and Diagnostic Test Accuracy Review.
    Pyo JS; Sohn JH; Kang G
    Pathol Oncol Res; 2016 Oct; 22(4):831-7. PubMed ID: 27197524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAF(V600E) Mutation Test in Papillary Thyroid Carcinoma.
    Pyo JS; Sohn JH; Kang G
    Endocr Pathol; 2015 Sep; 26(3):211-7. PubMed ID: 25957797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.
    Anwar MA; Murad F; Dawson E; Abd Elmageed ZY; Tsumagari K; Kandil E
    J Surg Res; 2016 Jun; 203(2):407-15. PubMed ID: 27363650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.
    Day F; Muranyi A; Singh S; Shanmugam K; Williams D; Byrne D; Pham K; Palmieri M; Tie J; Grogan T; Gibbs P; Sieber O; Waring P; Desai J
    Target Oncol; 2015 Mar; 10(1):99-109. PubMed ID: 24859797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer.
    Ko YS; Kim NY; Pyo JS
    Int J Biol Markers; 2018 Jan; 33(1):49-54. PubMed ID: 28478639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.
    Rössle M; Sigg M; Rüschoff JH; Wild PJ; Moch H; Weber A; Rechsteiner MP
    Virchows Arch; 2013 Nov; 463(5):623-31. PubMed ID: 24085553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of immunohistochemistry for the detection of the BRAF V600E mutation in colorectal carcinoma.
    Ioannou M; Papamichali R; Samara M; Paraskeva E; Papacharalambous C; Baxevanidou K; Koukoulis G
    J BUON; 2016; 21(3):618-25. PubMed ID: 27569082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
    Ilie MI; Long-Mira E; Hofman V; Mouroux J; Vignaud JM; Gauchotte G; Begueret H; Merlio JP; Emile JF; Hébuterne X; Hofman P
    Pathology; 2014 Jun; 46(4):311-5. PubMed ID: 24798160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of immunohistochemistry compared with molecular tests for detection of BRAF V600E mutation in ameloblastomas: Systematic review and meta-analysis.
    Martins-de-Barros AV; Anjos RSD; Silva CCG; Silva EDOE; Araújo FADC; Carvalho MV
    J Oral Pathol Med; 2022 Mar; 51(3):223-230. PubMed ID: 35090195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma.
    Pyo JS; Kim NY; Kim RH; Kang G
    Brain Tumor Pathol; 2016 Oct; 33(4):248-254. PubMed ID: 27638721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasms.
    Vakiani E; Yaeger R; Brooke S; Zhou Y; Klimstra DS; Shia J
    Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):438-43. PubMed ID: 25517872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance and diagnostic accuracy of HER2 immunohistochemistry in colorectal cancer: a meta-analysis.
    Pyo JS; Kang G; Park K
    Int J Biol Markers; 2016 Dec; 31(4):e389-e394. PubMed ID: 27102863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.
    Tetzlaff MT; Pattanaprichakul P; Wargo J; Fox PS; Patel KP; Estrella JS; Broaddus RR; Williams MD; Davies MA; Routbort MJ; Lazar AJ; Woodman SE; Hwu WJ; Gershenwald JE; Prieto VG; Torres-Cabala CA; Curry JL
    Hum Pathol; 2015 Aug; 46(8):1101-10. PubMed ID: 26058727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance rate between HER2 immunohistochemistry and in situ hybridization in gastric carcinoma: systematic review and meta-analysis.
    Pyo JS; Sohn JH; Kim WH
    Int J Biol Markers; 2016 Feb; 31(1):e1-10. PubMed ID: 26349670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.
    Jabbar KJ; Luthra R; Patel KP; Singh RR; Goswami R; Aldape KD; Medeiros LJ; Routbort MJ
    Am J Surg Pathol; 2015 Apr; 39(4):454-61. PubMed ID: 25634750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer.
    Martinuzzi C; Pastorino L; Andreotti V; Garuti A; Minuto M; Fiocca R; Bianchi-Scarrà G; Ghiorzo P; Grillo F; Mastracci L
    Endocrine; 2016 Sep; 53(3):672-80. PubMed ID: 26296380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.
    Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance and concordance analysis of c-MET immunohistochemistry in non-small cell lung cancers: A meta-analysis.
    Pyo JS; Kang G; Cho WJ; Choi SB
    Pathol Res Pract; 2016 Aug; 212(8):710-6. PubMed ID: 27465837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors.
    Hayashi Y; Sasaki H; Takeshita S; Nishikawa R; Nishikawa H; Arakawa A; Yamashita Y; Takahashi S; Sugiura-Ogasawara M
    Oncol Rep; 2014 Nov; 32(5):1815-9. PubMed ID: 25174456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
    Kuan SF; Navina S; Cressman KL; Pai RK
    Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.